NKTR Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 16:00):
Our systems believe the stock currently is overvalued by -1.61% compare to its pairs and should correct downwards.

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally...

Stats
Today's Volume	22.48M
Average Volume	2.31M
Market Cap	228.18M
EPS	$-0.190 ( Q1 \| 2024-05-10 )
Next earnings date	( $0 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.360 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00800 (0.66%)

AADI -10.43%

ABCL 2.78%

ABCM 0.04%

ABEO 1.19%

ABIO 6.39%

ABOS 2.54%

ABSI 0.98%

ABUS -0.32%

ABVX 3.69%

ACAD -0.73%

ACER -17.95%

ACET -9.70%

ACGN 1.29%

ACHL 0.62%

ACHV 1.29%

ACIU 0.50%

ACLX 1.98%

ACRV 0.69%

ACST -2.67%

ACXP -2.60%

ADAG 6.66%

ADAP -0.60%

ADGI 0.87%

ADIL 1.77%

ADMA 2.10%

ADPT 4.62%

ADTX -2.84%

ADVM -1.72%

ADXN -3.06%

AEON -0.94%

AEZS -2.64%

AFMD 0.00%

AGEN 18.63%

AGIO -1.12%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 3.11%

AKRO 0.26%

AKTX 0.75%

AKUS 0.00%

ALBO 0.00%

ALDX -2.65%

ALEC 0.00%

ALGS -7.51%

ALKS -0.78%

ALLK -5.66%

ALLO -4.51%

ALLR 3.85%

ALNA 3.16%

ALNY -1.62%

ALPN 0.02%

ALPX 0.00%

ALRN -4.48%

ALT 4.15%

ALVR -7.27%

ALXN 0.00%

ALXO 3.34%

ALZN -0.65%

AMRN -1.84%

AMTI -3.13%

ANAB 1.05%

ANEB 3.80%

ANGN 0.00%

ANIX -7.14%

ANL -6.05%

ANNX 1.66%

ANPC -3.15%

APGE -1.50%

APGN 8.48%

APGNW 30.65%

APLM 1.30%

APLS -7.61%

APLT 1.52%

APM -5.26%

APOP 0.38%

APRE -0.49%

APTO 1.20%

APTX 3.17%

APVO -40.57%

ARAV -13.39%

ARCT -0.41%

ARDS -17.87%

ARDX 14.00%

ARGX -3.35%

ARNA 0.00%

ARPO -0.90%

ARQT -1.27%

ARTL 3.08%

ARTLW 0.00%

ARVN 2.98%

ARWR 1.17%

ASLN 4.90%

ASMB -6.03%

ASND 0.72%

ATAI 0.76%

ATHA 0.38%

ATHE 0.56%

ATHX -33.50%

ATNF 9.27%

ATOS 4.39%

ATRA 2.91%

ATXI -2.23%

ATXS -1.30%

AUPH 1.60%

AURA 3.85%

AUTL 4.50%

AVBP 6.61%

AVEO 0.00%

AVIR -2.07%

AVRO -1.41%

AVTE -0.60%

AVTX -5.53%

AVXL -1.63%

AXLA 0.00%

AXSM 0.51%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.52%

BCAB -6.80%

BCDA -0.34%

BCDAW 0.00%

BCEL 0.00%

BCLI -6.08%

BCRX 1.15%

BCTX 9.62%

BCTXW 1.47%

BCYC -0.15%

BDRX 2.98%

BDTX -0.85%

BEAM -2.29%

BFRA -2.91%

BGNE -2.00%

BIOR 2.37%

BIVI -10.22%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -1.37%

BLTE -1.76%

BLU 0.03%

BLUE 3.74%

BMEA -0.66%

BMRN -1.40%

BNOX 3.51%

BNTC -0.71%

BNTX -0.02%

BOLD -14.76%

BOLT 0.32%

BPMC -0.68%

BPTH 2.56%

BPTS -13.47%

BRNS 1.45%

BRTX 10.93%

BTAI 0.79%

BTTX 30.91%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -2.44%

CABA 1.91%

CADL 5.26%

CALA 0.00%

CALC 25.71%

CALT 0.72%

CAPR 2.80%

CARA -15.27%

CARM 18.75%

CASI 12.24%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 3.79%

CCCC 0.00%

CCXI 0.00%

CDAK 0.00%

CDIO 0.37%

CDIOW 21.56%

CDMO 1.85%

CDMOP 0.04%

CDT 3.92%

CDTTW -12.92%

CDTX 6.70%

CDXC 3.02%

CDXS 2.99%

CELC 0.68%

CELU 11.79%

CELUW 0.00%

CERC -1.68%

CERE 0.96%

CERO -1.77%

CEROW 43.57%

CFRX -27.95%

CGEM 2.05%

CGEN -4.55%

CGON 4.36%

CGTX -0.60%

CHMA -6.00%

CHRS 1.76%

CINC 0.00%

CING -45.21%

CINGW 4.85%

CKPT 4.37%

CLBS -16.75%

CLDX -1.80%

CLGN -0.60%

CLLS 0.54%

CLNN -3.47%

CLNNW 3.32%

CLRB 7.30%

CLSD 1.56%

CLSN -0.68%

CLVS 0.00%

CMMB -4.26%

CMND 25.37%

CMPI 0.00%

CMPX -16.67%

CMRA 0.00%

CMRAW 33.33%

CMRX -1.47%

CNCE 0.00%

CNSP -4.82%

CNST 0.00%

CNTA 0.56%

CNTB 18.75%

CNTX -0.25%

COCP -8.63%

COEPW 0.00%

COGT -0.12%

CORT 1.34%

COYA -0.49%

CPRX 2.99%

CRBP 3.12%

CRBU -2.38%

CRDF -4.72%

CRGX 4.99%

CRIS -7.38%

CRNX 3.04%

CRSP -2.47%

CRTX 2.63%

CRVO -0.29%

CRVS -2.67%

CSBR 0.39%

CTCX 9.02%

CTIC 0.06%

CTMX -3.17%

CTNM -6.08%

CTXR -8.54%

CUE -11.43%

CVAC 1.19%

CVKD 1.82%

CWBR 0.00%

CYAD -12.96%

CYCC -4.71%

CYCCP -11.68%

CYCN 5.99%

CYT -2.27%

CYTK 0.74%

CYTO 0.00%

DARE -8.79%

DAWN -0.36%

DBTX -0.81%

DBVT -5.53%

DFFN 10.28%

DICE 0.06%

DMAC -3.28%

DNLI 1.09%

DNTH 3.85%

DOMH -1.58%

DRMA 4.37%

DRMAW 7.69%

DRNA 0.00%

DRTS 23.41%

DRTSW -8.84%

DRUG 2.32%

DSGN 0.00%

DTIL 3.29%

DYAI -6.33%

EARS -1.77%

EDIT -1.48%

EDSA -2.51%

EFTR -6.42%

EFTRW 0.00%

EIGR -9.21%

ELAB -1.48%

ELDN 1.54%

ELEV 7.57%

ELOX 12.20%

ELTX -40.35%

ELVN -0.34%

ELYM -5.58%

ENGN 5.13%

ENGNW -0.83%

ENLV -4.70%

ENOB 1.79%

ENSC -2.78%

ENTA 2.37%

ENTO 2.51%

ENTX -5.64%

ENVB 0.71%

EPIX 1.54%

EPRX 0.78%

EPZM 0.00%

EQ 3.77%

EQRX -2.09%

EQRXW 0.00%

ERAS 2.16%

ERNA 5.17%

ERYP 1.30%

ESLA 12.90%

ESLAW 0.00%

ETNB 6.23%

ETON -0.90%

ETTX 0.00%

EVAX 1.05%

EVGN -5.74%

EVLO 0.00%

EWTX 2.91%

EXAI -2.30%

EXEL -0.27%

EYEG -0.50%

EYEN -14.16%

EYPT -0.57%

FATE 0.46%

FBIO 1.79%

FBIOP 1.02%

FBLG 7.08%

FBRX -2.01%

FDMT 0.29%

FENC -0.65%

FGEN -13.37%

FHTX 0.17%

FIXX 0.77%

FMTX 0.00%

FNCH 13.22%

FOLD 0.10%

FREQ 4.76%

FRLN 0.15%

FRTX 5.56%

FSTX 0.00%

FTRE 2.01%

FULC -1.27%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 2.73%

GANX 2.40%

GBIO -1.05%

GBT 0.01%

GDTC 5.05%

GERN -4.50%

GHRS -2.75%

GLMD 2.46%

GLPG -1.43%

GLSI 2.25%

GLTO -5.16%

GLUE 10.65%

GLYC -11.22%

GMAB -1.76%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -6.48%

GNLX -11.36%

GNPX -3.33%

GNTA -0.32%

GOSS -5.38%

GOVX -10.28%

GOVXW -20.59%

GPCR 0.33%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -12.42%

GRTX 1.33%

GTHX 1.33%

GUTS -3.61%

GXGXW 41.67%

GYRE 20.63%

HALO 1.41%

HARP 0.09%

HCWB 1.06%

HEPA -5.55%

HGEN -84.62%

HILS 5.66%

HLVX 8.15%

HOOK -8.97%

HOTH -0.79%

HOWL -2.79%

HRMY -4.16%

HRTX 2.64%

HSTO 0.00%

HUMA 2.13%

HUMAW -1.42%

IBRX -3.36%

ICCC 11.24%

ICPT 0.21%

ICU 10.16%

ICUCW 12.50%

ICVX -0.91%

IDRA -23.04%

IDYA 2.15%

IFRX 4.19%

IGMS 3.93%

IKNA -5.71%

IKT -12.32%

IMAB -1.18%

IMCR 0.33%

IMGN 0.02%

IMGO 0.00%

IMMP 7.49%

IMMX -7.04%

IMNM 1.09%

IMNN 0.87%

IMPL -27.27%

IMRA 15.96%

IMRN -3.97%

IMRX -10.49%

IMTX -1.44%

IMTXW 2.21%

IMUX 8.82%

IMV 0.00%

IMVT 1.54%

INAB -5.87%

INBX 0.78%

INCY -1.19%

INDP -7.02%

INFI -52.38%

INKT 2.06%

INM 0.19%

INMB 1.50%

INO 4.12%

INSM 0.07%

INTS 0.20%

INVA 1.23%

INZY -1.33%

IOBT -0.85%

IONS 0.91%

IOVA 0.12%

IPA 1.23%

IPHA -1.52%

IPSC 0.79%

IRON 1.62%

ISEE 0.38%

ITOS -4.26%

ITRM -4.58%

IVA -0.33%

IVVD -8.33%

JAGX -1.11%

JANX 3.84%

JAZZ -0.35%

JNCE 0.00%

JSPR 3.13%

JSPRW 5.15%

JUNS 0.00%

JUNSW 0.00%

KA -5.43%

KALV -2.24%

KDNY 0.22%

KMPH -0.34%

KNSA 0.43%

KNTE -0.38%

KOD -3.29%

KPRX 1.20%

KPTI -10.84%

KRBP 6.83%

KRON 3.33%

KROS 1.40%

KRRO 1.20%

KRTX 0.03%

KRYS 0.42%

KTRA -3.60%

KTTA 1.62%

KTTAW 0.92%

KURA 0.44%

KYMR -1.22%

KYTX 1.90%

KZIA 2.65%

KZR -5.41%

LABP 0.57%

LBPH 20.19%

LBPS 0.00%

LBPSW 14.81%

LEGN -0.83%

LENZ -2.92%

LEXX 5.70%

LEXXW -5.15%

LGND 2.34%

LGNDV 0.00%

LGVN -4.17%

LIAN -8.28%

LIFE 2.70%

LIPO -3.43%

LIXT -2.47%

LIXTW -3.71%

LJPC -0.32%

LMNL 0.12%

LOGC -2.06%

LPCN 6.32%

LPTX 10.73%

LQDA -3.07%

LRMR -1.36%

LSTA -0.57%

LTRN 2.86%

LUMO 2.20%

LVTX -3.74%

LXEO 7.94%

LXRX -3.45%

LYEL 5.07%

LYRA 5.93%

MACK 0.10%

MBIO 1.59%

MBRX -3.83%

MCRB -7.80%

MDGL -1.93%

MDNA -13.16%

MDWD 4.30%

MDXG 2.51%

MEIP -1.36%

MESO -0.58%

MGNX 3.16%

MGTA -7.74%

MGTX -0.47%

MGX 8.22%

MIRM 3.26%

MIRO 0.59%

MIST 2.33%

MITO 0.00%

MLEC 1.85%

MLECW -28.57%

MLND -5.36%

MLTX 5.47%

MLYS 1.74%

MNKD -1.32%

MNMD -0.55%

MNOV 0.00%

MNPR -1.67%

MOLN 4.33%

MOR 0.17%

MORF 0.18%

MREO 3.45%

MRKR 12.42%

MRNA -2.01%

MRNS -4.88%

MRSN 0.75%

MRTX -0.17%

MRUS -1.71%

MRVI 1.13%

MTCR -1.29%

MTEM 3.60%

MTP -18.50%

MURA 2.28%

MYMD -1.08%

NAMS -1.69%

NAMSW -3.11%

NAUT 2.63%

NBRV 0.71%

NBSE -1.56%

NBTX -10.71%

NCNA -4.49%

NERV 4.59%

NEXI 0.00%

NGM -1.28%

NGNE 4.51%

NKGN 2.42%

NKGNW -12.00%

NKTR 8.77%

NKTX 0.85%

NLSP -9.63%

NLSPW 7.48%

NMRA 6.85%

NMTR -42.97%

NOVN -24.84%

NRBO 0.83%

NRIX 0.63%

NRSN 9.80%

NRSNW 21.18%

NRXP -6.87%

NRXPW -16.53%

NRXS 4.51%

NTBL -6.32%

NTEC -12.45%

NTHI 0.00%

NTLA -3.49%

NTRBW 74.65%

NUVL -1.44%

NVAX -1.33%

NVCT 0.96%

NVIV -34.28%

NXTC -3.05%

NYMX -0.05%

OABI -0.53%

OABIW 6.37%

OBIO 2.77%

OBSV 0.00%

OCEA -11.59%

OCGN 8.39%

OCS 1.44%

OCUL 1.18%

OCUP 0.66%

ODT -4.27%

OKYO 0.85%

OLMA -3.48%

OMER 2.78%

OMGA -7.59%

ONCO -18.40%

ONCR -3.08%

ONCS 31.87%

ONCT -1.17%

ONCY -1.98%

ONTX -0.47%

ONVO -0.41%

OPNT 0.00%

OPT 3.21%

ORGS -5.36%

ORIC 2.32%

ORMP -4.10%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.73%

OVID 5.89%

OYST 0.00%

PALI -1.53%

PASG -14.04%

PBLA 11.11%

PBM -8.81%

PBYI 0.93%

PCSA 8.21%

PCVX -4.14%

PDSB -2.66%

PEPG -3.04%

PGEN 4.64%

PHAR 3.47%

PHAS 0.00%

PHAT -0.96%

PHIO 1.75%

PHIOW 36.47%

PHVS 4.39%

PHXM -5.20%

PIRS 5.83%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 0.84%

PLUR 7.04%

PMN -1.96%

PMVP -2.41%

PNT 0.16%

PPBT -6.42%

PRAX 4.02%

PRDS 0.93%

PRLD 3.25%

PROG -3.47%

PROK 1.65%

PRQR 0.61%

PRTA 0.54%

PRTC 4.56%

PRTG -6.11%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -1.34%

PSTX 7.35%

PTCT -11.77%

PTE -0.82%

PTGX 8.69%

PTIXW -47.77%

PULM 0.52%

PXMD -9.45%

PYPD 3.12%

PYXS 3.12%

QLGN -3.31%

QNCX 4.87%

QNRX -2.85%

QSI 11.70%

QSIAW 4.08%

QTTB 17.70%

QURE -1.32%

RAIN -1.63%

RANI -3.55%

RAPT 5.54%

RARE -0.77%

RCKT 0.47%

REGN 0.02%

RENB 16.67%

REPL 5.63%

RETA 0.02%

REUN -0.89%

REVB 2.69%

REVBU 3.46%

REVBW 19.05%

RGLS -11.85%

RGNX 0.60%

RIGL -13.75%

RLAY 3.49%

RLMD 0.33%

RLYB -9.46%

RNA 0.76%

RNAC -5.29%

RNAZ -0.50%

RNXT -2.59%

ROIV 0.00%

ROIVW 4.56%

RPHM -6.21%

RPRX -1.12%

RPTX -2.37%

RUBY 2.70%

RVLP -32.05%

RVMD 0.73%

RVMDW 45.86%

RVNC -0.39%

RVPH 0.00%

RVPHW 1.89%

RXDX 0.09%

RXRX -0.99%

RYTM 2.32%

RYZB 0.02%

RZLT 7.23%

SABS 6.16%

SABSW 35.43%

SAGE 1.59%

SANA 1.11%

SAVA -34.83%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -2.80%

SCPH -0.46%

SCPS 0.00%

SEEL -2.10%

SEER -4.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -10.11%

SGMT -16.79%

SGTX -2.56%

SIOX 22.63%

SLDB -1.22%

SLGL 3.37%

SLN 0.00%

SLNO -2.28%

SLRX -2.86%

SLS 4.39%

SMMT -0.89%

SNDX 1.03%

SNGX -7.19%

SNPX 0.99%

SONN -1.41%

SPPI -0.49%

SPRB -2.72%

SPRC -5.99%

SPRO -2.99%

SRNE 5.26%

SRPT 0.03%

SRRA 0.00%

SRRK -0.36%

SRZN 10.16%

STAB 0.00%

STOK 1.50%

STRO 0.34%

STSA 0.00%

STTK 2.93%

SURF -0.93%

SVRA 5.77%

SWTX 0.37%

SYBX -1.96%

SYRS -9.95%

TALS -0.73%

TARA -4.15%

TARS 7.99%

TBPH 1.80%

TCBP -1.31%

TCDA 0.00%

TCON -1.38%

TCRR 0.00%

TCRT -2.92%

TCRX -6.25%

TECH -0.24%

TENX 1.17%

TERN -4.22%

TFFP 3.11%

TGTX -0.89%

THRX 0.12%

TIL -1.06%

TLC 0.00%

TLSA 4.43%

TNGX 0.47%

TNXP 1.07%

TNYA 5.44%

TPST 0.92%

TRDA 0.56%

TRVI 1.36%

TRVN 1.40%

TSHA 3.46%

TSVT 2.39%

TTNP 0.91%

TVTX -0.72%

TYRA 3.50%

UBX -2.17%

UNCY 23.70%

URGN -1.12%

UTHR 0.51%

VACC 11.36%

VALN -5.14%

VAXX -0.24%

VBIV 1.54%

VBLT -8.77%

VCEL -2.20%

VCNX 2.69%

VCYT -1.46%

VERA 4.39%

VERU 5.16%

VERV 2.52%

VIGL -10.71%

VINC 9.46%

VIR 0.34%

VIRI -8.20%

VIRX -5.93%

VKTX 4.41%

VLON -13.04%

VNDA -2.75%

VOR -12.28%

VRCA 0.97%

VRDN 1.80%

VRNA -6.35%

VRPX -0.52%

VRTX -0.80%

VSTM 2.76%

VTGN 0.00%

VTVT -0.34%

VTYX -3.35%

VXRT 0.20%

VYGR 0.64%

VYNE 0.00%

VYNT 7.78%

WINT -3.60%

WVE 0.00%

XBIO 1.50%

XBIT 11.50%

XCUR 5.89%

XENE 4.22%

XERS -0.44%

XFOR -13.45%

XLO 0.80%

XLRN 0.00%

XNCR -1.41%

XOMA 3.45%

XOMAO 0.24%

XOMAP 0.08%

XRTX 0.00%

YMAB -2.03%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -1.08%

ZNTL -2.62%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-14	Chess Robert	Sell	19 500	Common Stock
2024-05-17	Robin Howard W	Sell	16 650	Common Stock
2024-05-17	Zalevsky Jonathan	Sell	7 355	Common Stock
2024-05-17	Wilson Mark Andrew	Sell	6 260	Common Stock
2024-05-10	Deep Track Capital, Lp	Sell	56 000	Common Stock

INSIDER POWER
76.98
Last 97 transactions
Buy: 6 900 913 \| Sell: 715 783

Correlation (AI algo v.1.1b): Overvalued: -1.61% $1.240 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.47 (neutral)

Short: -0.89 (strong negative)

Signal:(34.833) Neutral

Nektar Therapeutics Correlation

10 Most Positive Correlations
PAYS	0.964
USAP	0.959
GDST	0.958
VCTR	0.953
IVCB	0.952
GGAL	0.949
SMTC	0.946
PRIM	0.945
MESO	0.944
KALU	0.944

10 Most Negative Correlations
VEEE	-0.959
INTZ	-0.953
JACK	-0.951
FAIL	-0.948
ALLR	-0.943
SIRI	-0.941
APDN	-0.939
LCFY	-0.935
XPON	-0.934
SSYS	-0.932

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nektar Therapeutics Correlation - Currency/Commodity

-0.43
( neutral )

-0.27
( neutral )

0.00
( neutral )

0.53
( weak )

Nektar Therapeutics Financials

Annual	2023
Revenue:	$90.12M
Gross Profit:	$53.48M (59.34 %)
EPS:	$-1.450

FY	2023
Revenue:	$90.12M
Gross Profit:	$53.48M (59.34 %)
EPS:	$-1.450

FY	2022
Revenue:	$92.06M
Gross Profit:	$70.42M (76.50 %)
EPS:	$-1.970

FY	2021
Revenue:	$101.91M
Gross Profit:	$77.01M (75.57 %)
EPS:	$-2.86

Financial Reports:

No articles found.

Nektar Therapeutics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Nektar Therapeutics

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the treatment of solid tumors; and phase 1B clinical trial to treat COVID-19. It is also developing NKTR-358, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; NKTR-255, an IL-15 receptor agonist, which is in phase 1/2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer and colorectal cancer; and NKTR-262, a toll-like receptor agonist that is in phase 1/2 clinical trial to treat solid tumors, as well as various other drug candidates. The company has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. Nektar Therapeutics was incorporated in 1990 and is headquartered in San Francisco, California.